73.6 F
Clearwater
Tuesday, May 18, 2021
news:-synthetic-biology-for-tennessee-schools:-biobuilder-partners-with-niswonger-foundation-on-$8.8m-federal-grant-for-stem-education-|-citizenwire

News: Synthetic Biology for Tennessee Schools: BioBuilder Partners with Niswonger Foundation on $8.8M Federal...

CAMBRIDGE, Mass. /CitizenWire/ -- The BioBuilder Educational Foundation announced that they are to partner with the Niswonger Foundation on their award of an "Education Innovation and Research" (EIR) Grant from the U.S. Department of Education that will focus on educational opportunities in Science, Technology, Engineering and Mathematics (STEM). BioBuilder will provide teacher professional development in…
china-is-using-human-testing-to-develop-‘biologically-enhanced’-soldiers,-top-intelligence-official-says

China Is Using Human Testing To Develop ‘Biologically Enhanced’ Soldiers, Top Intelligence Official Says

China has conducted human testing on members of its military in an effort to develop “biologically enhanced” soldiers, Director of National Intelligence John Ratcliffe wrote in a Wall Street Journal op-ed Thursday. .@DNI_Ratcliffe outlines why China is a “once-in-a-generation challenge” and the greatest national security threat America faces in a @WSJ op-ed: https://t.co/Qk0UPgwtQG — Office…
news:-zeteo-biomedical-to-collaborate-with-iowa-state-university-nanovaccine-institute-to-study-a-covid-19-vaccine-under-fast-track-cares-act-funded-program-|-citizenwire

News: Zeteo Biomedical to Collaborate with Iowa State University Nanovaccine Institute to Study a...

A nasal vaccine that can be self-administered is crucial to protect global populations against pandemic virus threats AUSTIN, Texas /CitizenWire/ -- Zeteo Biomedical LLC, Inc., a privately held medical device company, has partnered with the Nanovaccine Institute at Iowa State University to study a nasal SARS-CoV-2 vaccine. Zeteo will provide nasal delivery device technology and…
citizenwire:-progenabiome-shares-new-data-on-fecal-transplant,-sars-cov-2-at-acg-2020

CitizenWire: Progenabiome Shares New Data on Fecal Transplant, Sars-Cov-2 at ACG 2020

VENTURA, Calif. /CitizenWire/ -- The American College of Gastroenterology (ACG) named Progenabiome "Outstanding Poster Presenter" for its poster: "Successful Bacterial Engraftment Identified by Next Generation Sequencing Following Fecal Microbiota Transplantation for Clostridioides difficile Infection," which will be presented virtually at the ACG Annual Scientific Meeting this week. From close to 2900 posters, only roughly 10%…
news:-pure-protein,-llc-to-exhibit-and-preview-new-website-at-the-american-society-for-histocompatibility-and-immunogenetics-(ashi)-46th-annual-meeting

NEWS: Pure Protein, LLC to Exhibit and Preview New Website at the American Society...

OKLAHOMA CITY, Okla., Oct 15, 2020 (SEND2PRESS NEWSWIRE) -- Pure Protein, LLC (Pure Protein) an HLA company that has developed comprehensive analytical capabilities in the field of human leukocyte antigen (HLA) immunology and an approach to produce soluble forms of the HLA molecule (sHLA), announced today that it will be an exhibitor at the ASHI…
news:-zeblok-computational-announces-partnership-with-laufer-center-and-cewit-–-covid-19-drug-discovery

NEWS: Zeblok Computational Announces Partnership with Laufer Center and CEWIT – COVID-19 Drug Discovery

STONY BROOK, N.Y., Jul 20, 2020 (SEND2PRESS NEWSWIRE) -- Zeblok Computational is contributing to the efforts of two groups of researchers at The Laufer Center for Physical and Quantitative Biology, for COVID-19 drug discovery by providing Zeblok's secure, scalable Supercomputing-as-a-Service platform, employing 128 GPUs from the CEWIT SMART GPU Cluster. The Laufer Center simulations focus…
news:-rokit-pharma’s-preclinical-studies-showing-tremendous-promise-for-naturally-derived-cancer-drug,-rok-001-–-moving-towards-the-initiation-of-phase-1b/2-clinical-trial

NEWS: ROKiT Pharma’s Preclinical Studies Showing Tremendous Promise for Naturally Derived Cancer Drug, ROK-001...

LOS ANGELES, Calif., Apr 02, 2020 (SEND2PRESS NEWSWIRE) -- ROKiT Pharma, Inc., a public-benefit corporation dedicated to putting patients first, announced today it is rapidly progressing through final preclinical studies and moving forward with preparation for the initiation of a Phase 1b/2 clinical trial of ROK-001, a potentially low toxicity cancer drug derived from natural…
news:-lyme-disease-biobank-expands-into-san-diego

NEWS: Lyme Disease Biobank Expands Into San Diego

SAN DIEGO, Calif., Mar 06, 2020 (SEND2PRESS NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the U.S., announces the opening of the San Diego collection site of the Bay Area Lyme Foundation's Lyme Disease Biobank, which is the first program to provide researchers with blood and urine samples from…
news:-icell-gene-therapeutics-announces-car-t-oral-and-poster-presentations-at-61st-american-society-of-hematology-annual-meeting

NEWS: iCell Gene Therapeutics Announces CAR-T Oral and Poster Presentations at 61st American Society...

STONY BROOK, N.Y., Nov 14, 2019 (SEND2PRESS NEWSWIRE) -- iCell Gene Therapeutics, a clinical stage biopharmaceutical company focused on immunotherapies for hematologic malignancies, solid tumors, organ rejections and autoimmune disorders, announced today that it will give oral and poster presentations related to its BCMA-CD19 cCAR and CD4-specific CAR programs at the 61st American Society of…
news:-hans-van-der-sluijs-joins-biotork-as-chief-development-officer

NEWS: Hans van der Sluijs Joins BioTork as Chief Development Officer

GAINESVILLE, Fla., Oct 30, 2019 (SEND2PRESS NEWSWIRE) -- BioTork, the leading evolution biotechnology company, today announced that biotech executive Hans van der Sluijs has joined the company as Chief Development Officer. Hans brings over 20 years of international business leadership experience, with a focus on business development, management, and building strategic alliances/partnerships. Hans will be…
3,789FansLike
5,487FollowersFollow
543FollowersFollow
30,600SubscribersSubscribe

Recent Posts

USD - United States Dollar
EUR
1.221
GBP
1.419
AUD
0.779
HKD
0.129
CHF
1.113
JPY
0.009